Two Sigma Investments
EBS icon

Two Sigma Investments’s Emergent Biosolutions EBS Stock Holding History

Two Sigma Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,900
Closed -$396K – 4410
2021
Q3 		$396K Buy
7,900
+1,900
+32% +$115K ﹤0.01% 3446
2021
Q2 		$378K Buy
+6,000
New +$385K ﹤0.01% 3321

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Two Sigma Investments's EBS Position: Q1 2026 in Review

Two Sigma Investments increased its Emergent Biosolutions (EBS) stake by 123% in Q1 2026, buying an estimated $3.3M and bringing the position to 577,128 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Two Sigma Investments first reported a position in EBS in Q2 2013 and has held it in 35 quarters since. The position peaked at $28.7M in Q3 2020. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Two Sigma Investments held 577,128 shares of Emergent Biosolutions worth $4.79M as of Q1 2026.
  • Two Sigma Investments bought 318,628 Emergent Biosolutions shares in Q1 2026, an estimated $3.3M.
  • Emergent Biosolutions made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2016 holding.
  • Two Sigma Investments first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 35 quarters since.
  • Two Sigma Investments's Emergent Biosolutions position peaked at $28.7M in Q3 2020.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.